CroiValve

CroiValve

CroíValve is an early-stage medical device company focused on developing a minimally invasive device for treating tricuspid regurgitation. Based in Dublin, they combine significant clinical, technical and commercial expertise.

Treating tricuspid regurgitation is very challenging, with limited treatment options.

A novel device that combines repair & replacement. It is implanted without the need for complex surgery, and one size implant fits all heart valve sizes.

Website

LinkedIn

PreviousNext

Other Portfolio Companies

VertiGenius

VertiGenius are developing a new way to consult and manage patients with vertigo, imbalance, and dizziness.

X-Bolt Orthopedics

Focused on research, development, and commercialization of highly innovative fixation devices for treatment of hip fractures.

Bluedrop Medical

Bluedrop Medical is focused on developing a device which can predict the formation of diabetic foot ulcers.

Tympany Medical

Tympany Medical are designing endoscopes at the leading edge of design, electronics, photonics and engineering.

Disclaimer

Ascentifi does not and will not provide any form of financial services or investment advice to any party. We do not promote, recommend, or sell investments. We bring start-up companies to the attention of investors. If an investor chooses to invest, we help facilitate the investment process.

The investment decisions an investor makes are the sole responsibility of the investor. Ascentifi does not assess the appropriateness of an investors investment experience and knowledge when bringing start-up companies to their attention.

Please read our full Disclaimer

Risk Warning

Investing involves risks, including total loss of capital, illiquidity, dilution, and lack of dividends. It is suitable only for investors capable of evaluating and bearing those risks.

Your investment is not covered by the deposit guarantee schemes established in accordance with Directive 2014/49/EU of the European Parliament and of the Council. Nor is your investment covered by the investor compensation schemes established in accordance with Directive 97/9/EC of the European Parliament and of the Council.

Please read our full Risk Warning

Tympany MedicalBluedrop Medical